Monday, July 29, 2013
Fishing for chips
Tuesday, July 23, 2013
Does the human voice calm horses?
Monday, July 22, 2013
Improving management of wild horses and burros
Thursday, June 27, 2013
Hendra Virus Research Program
HHALTER (Horse owners and Hendra Virus: A Longitudinal cohort study To Evaluate Risk) is a three-year project funded by the Commonwealth of Australia, the State of New South Wales, the State of Queensland and the Rural Industries Research and Development Corporation under the National Hendra Virus Research Program.
The project aims to look at how humans respond to the threat of Hendra virus, and what can be done by horse owners and others in regular contact with horses to reduce the chance of transmission from flying foxes to horses and then to humans.
The researchers hope to attract more than 2500 people, horse owners and people in regular contact with horses, from all sectors of the equine industry throughout Australia. It is not only residents of areas where Hendra virus cases have already occurred that are sought for the study. People living in parts of Australia that have not seen cases of the disease are encouraged to take part as well.
Participants are asked to complete five surveys conducted at six-month intervals. The surveys investigate the factors influencing people’s awareness about the risks from Hendra virus and their use of prevention strategies.
Dr Kate Sawford, Research Associate in Animal Health Biosecurity at the University of Sydney, said: “The combination of a high human death rate, no cure and no human vaccine means that Hendra virus is a frightening disease. An outbreak of Hendra virus on a property cannot only impact people’s health, but also be financially, professionally, emotionally and psychologically damaging.
The first survey with horse owners and horse care providers has now been completed. This focused on Hendra virus risk awareness, perceptions and knowledge, with large sections dedicated to practices employed on properties to limit the risk from the virus and attitudes to vaccination.
Another four surveys with horse owners and horse care providers will be conducted over the next two years.
To participate in the research project or find out more information visit http://www.uws.edu.au/hhalter
A brief summary of some preliminary findings is available in the first HHALTER Project Research Newsletter.
Tuesday, June 25, 2013
Tick paralysis high death rate
Findings presented at the Australian Veterinary Association conference showed that 26% of affected horses died and 35% of surviving horses developed one or more complications.
Tick paralysis,is caused by the Australian paralysis tick Ixodes holocyclus, and has been known to affect horses since the early days of Australian settlement.
Dr Mick Ruppin, one of the co-authors of the study explained: “The paralysis tick is found predominantly along the east coast of Australia, in high rainfall areas. Our study was a retrospective analysis of cases treated at our practice on the east coast of Queensland, over the last ten years, as well as cases treated at other practices along the east coast over the last five years. A total of 103 cases were analysed.
“The number of paralysis ticks required to paralyse a horse is unknown but our study included cases where large horses with only one to two ticks were paralysed and unable to stand. Horses of any age and size can be affected by tick paralysis” Dr Ruppin added.
“The mortality rate of 26% in horses is much higher than the mortality rate in small animals which is around five per cent.
Dr Ruppin said that higher mortality rates in horses could be due to a range of factors including horses being badly affected before vets are called; difficulties associated with nursing a recumbent horse; difficulties with owners needing to deliver the bulk of nursing care and lack of information to veterinarians treating the disease in horses.
“In our study, 26 % of the horses died and of the surviving horses, 35% developed one or more complications including pressure sores, corneal ulcers, pneumonia and sepsis.
“Given the difficulties associated with treating tick paralysis in horses, prevention is the best option for horse owners,” he said.
Read more at equinescienceupdate.com
Sunday, June 23, 2013
Sycamore linked to Atypical Myopathy
Toxic seeds of the sycamore (Acer pseudoplatanus) are the likely cause of Atypical Myopathy (AM) Atypical Myopathy is a highly fatal muscle disease of horses in the UK and Northern Europe. In ten years, approximately twenty European countries have reported the disease. Incidences tend to occur repeatedly in the autumn and in the spring following large autumnal outbreaks. Horses that develop AM are usually kept in sparse pastures with an accumulation of dead leaves, dead wood and trees in or around the pasture and are often not fed any supplementary hay or feed.
A very similar disorder, Seasonal Pasture Myopathy (SPM), which occurs in Midwestern USA and Eastern Canada, is now known to be caused by a toxin (hypoglycin A), contained in seeds from the box elder tree.
The European research team, led by Dominic Votion, of the University of Liege, studied 17 horses from Belgium, Germany and The Netherlands, suffering from Atypical Myopathy. They found high concentrations of methylenecyclopropyl acetic acid (MCPA), a toxic metabolite of hypoglycin A, in the serum of all affected horses.
The pastures of 12 of the horses were visited by experienced botanists and Acer pseudoplatanus, the sycamore maple, was found to be present in every case. This was the only tree common to all visited pastures. Acer negundo, the box maple, was not present on any of the farms on which atypical myopathy occured.
Researchers believe hypoglycin A is the likely cause of both AM in Europe and SPM in North America. The sycamore and the box elder are known to produce seeds containing hypoglycin A and the pastures of the afflicted horses in Europe and the USA were surrounded by these trees.
in European horses, according a new study.
Read more at equinescienceupdate.com
Sunday, June 16, 2013
More help needed for saddle slip study
Horse riders are being asked to help with an important research project looking into the interaction between horse, saddle and rider. Researchers, led by Dr Sue Dyson, Head of Clinical Orthopaedics at the Centre for Equine Studies at the Animal Health Trust, are running a detailed study to find out how the horse, rider and saddle influence each other. In particular they want to understand better why some saddles persistently slip to one side in some horses.
Saddle slip in sports horses is a well-recognised problem that can occur for a variety of reasons, including asymmetry in the shape of the horse’s back, riders sitting crookedly and ill-fitting saddles.
Participants in the study simply need to complete an anonymous online questionnaire. In doing so the researchers say that they will be helping to protect and improve the future health, welfare and longevity of the ridden horse.
Preliminary invevstigations have looked at just over 700 riders, but for a more accurate picture the research team would like to include more than 1000 people.
“We are urging all riders, whatever their level or ability, to help by completing the questionnaire,” said Line Greve, a PhD student at the Centre for Equine Studies.
“Saddle slip is a problem seen in all sorts of horses and ponies and can contribute to back pain and thus impaired performance,” she explains. “Research suggests that 25% of British dressage horses have a history of back-related problems and subsequent reduced performance.”
The online questionnaire should take no more than 15 minutes to complete. The questions cover saddle types, use and maintenance as well as rider experience and training, and any previous equine lameness or back-related problems.
Participants will remain anonymous and the results will be presented at the Saddle Research Trust Conference in 2014.
To take part in the study, follow this link to the questionnaire
http://www.aht.org.uk/cms-display/premise_questionnaire.html.
Thursday, June 06, 2013
Sperm from dead horses
Or you may have a promising colt and be unable to decide between keeping him entire for breeding, or having him castrated. The answer may lie in cryopreservation of epididymal sperm.
It is now possible to salvage sperm from the tail of the epididymis – the long convoluted tube into which the sperm pass after being produced in the testis. As well as acting as a reservoir for the sperm, the epididymis provides an environment in which they can mature and become able to fertilise oocytes.
The procedure for harvesting and freezing the sperm is not widely available. So what can be done if the laboratory is a long way away? Will delay adversely affect the viability of the sperm?
Research in the Department of Physiology at the University of Murcia in Spain suggests that spermatozoa stored in the epididymis for up to 96 hours at 4º C can be cryopreserved successfully and still retain the ability to fertilise.
In work published in the journal Animal Reproduction Science, Luis Vieira and others studied the viability of sperm stored in the epididymis obtained from castrated horses.
Testes were transported to the laboratory in insulated containers at ambient temperature within one hour of castration. At the laboratory, the epididymides were washed in physiological saline, wrapped in foil to prevent them drying out, and stored in a refrigerator at 4º C for up to 96 hours.
The scientists harvested the sperm by introducing a syringe and needle into the vas deferens and flushing out the epididymal contents. The sperm were mixed with extender before being frozen and stored in liquid nitrogen.
Measurements of viability of sperm in the epididymal fluid were made at various stages in the procedure.
Viability was good (85%) if the sperm were harvested on the day of castration , and remained at more than 80% until 72 hours after castration. Sperm stored for 96 hours before harvesting were significantly less viable.
After dilution in the freezing media and storage at 4º C for 30 minutes, viability remained good for sperm harvested within 48 hours of castration. Viability was lower in sperm collected 72 and 96 hours after castration.
On the other hand, time (up to 96 hrs) from castration to harvesting did not appear to affect the viability after freezing and thawing, which was almost 35%.
Other measures of sperm viability and tests of their ability to fertilise in vitro, were carried out, including chromatin condensation, ROS generation, protein tyrosine phosphorylation and heterologous fertilization rate. These showed that epididymal stallion sperm stored for up to 72h in the epididymis at 4°C followed by cryopreservation, maintained both viability and ability to fertilize in vitro.
Although these were laboratory tests of viability, epididymal sperm have been used successfully.
Read more at equinescienceupdate.com
Tuesday, June 04, 2013
When to stop Lyme disease treatment?
Lyme disease (LD) is caused by systemic infection with the spirochaete Borrelia burgdorferi. The most common signs in affected animals are lameness, often affecting more than one limb, and reluctance to work. Diagnosis of the disease is complicated by the many other possible causes of lameness and the high incidence of sub-clinical infection in areas in which the infection occurs. Many clinically normal animals have antibodies to Borrelia burgdorferi in their blood.
How do you decide on the length of treatment course necessary in cases of Lyme disease in horses?
Changes in the antibody levels are often used to assess when treatment has been successful. In experimental infections, infected animals show marked reduction in antibody levels after antibiotic treatment.
Does the same apply to naturally infected cases? Research in New York State suggests that ELISA serology is less helpful in those cases for determining when treatment is complete.
The study saw Dr Thomas J Divers and colleagues at Cornell Veterinary School collaborating with Dr Amy L Grice of the Rhinebeck Equine practice in New York State.
Thomas J Divers and colleagues at Cornell Veterinary School and Dr Amy L Grice of the Rhinebeck Equine practice compared Borrelia ELISA antibody concentrations in naturally exposed horses before and after antibiotic treatment for Lyme disease. The study included 68 horses treated with doxycycline or oxytetracycline and 183 horses that received no treatment.
They found that antibiotic treated horses had a decline in ELISA values in comparison to control horses. The scale of the decline in ELISA units following treatment was small compared to that previously reported in experimentally infected and treated ponies.
They conclude: “Persistently high ELISA titres following appropriate treatments for Lyme disease may not, without appropriate clinical signs, be a reason for more prolonged treatment.”
Read more at equinescienceupdate.com
Friday, May 31, 2013
Healthy horses needed for research study in Saskatchewan
Researchers at the Western College of Veterinary Medicine (WCVM) in Saskatoon are looking to enrol between 40 and 50 healthy horses for a respiratory study this summer.
The study, led by Dr Julia Montgomery and Dr Katharina Lohmann, aims to determine reliable reference ranges for two common tests used to investigate respiratory disease in horses.
In the WCVM newsletter, Christina Weese writes that that questions about the two tests initially arose when a graduate student was studying lung inflammation markers in normal horses.
“We started looking at what the expected ranges for two common tests – tracheal wash and bronchoalveolar lavage (BAL) – were supposed to be,” explains Dr. Montgomery, an assistant professor in the WCVM’s Department of Large Animal Clinical Sciences.
“In the course of the study, we came across several horses that looked clinically healthy, but their tracheal wash and BAL levels were - according to the current definition - not normal.”
To be eligible for the study, horses should have no history of chronic airway disease, no history of respiratory disease within the last six months and no clinical symptoms at the time of the study. Also, to ensure collected samples remain viable, horses must be within two to three hours’ drive from the WCVM.
An initial examination will identify whether the animal is suitable for the study. The clinicians will perform a clinical examination, including listening to the heart and lungs and checking the temperature. They will also carry out a rebreathing test. This involves placing a bag over the horse's nose, making him breathe deeply, which may make any abnormalities in the lungs easier to detect.
If any signs of abnormality are discovered, the horse will not be suitable for the study and no further tests will be carried out.
If the respiratory system appears normal then further tests to sample fluids from the trachea (“tracheal wash”) and lungs (“brocho-alveolar lavage”) will be performed under sedation.
After samples are collected, team members will examine the blood work for any evidence of inflammation. Dr. Hilary Burgess, a veterinary clinical pathologist at the WCVM, is collaborating with Montgomery and Lohmann to do a cytological analysis of the tracheal wash and BAL samples. The samples will also be sent to the bacteriology lab at Prairie Diagnostic Services (Saskatchewan’s provincial veterinary laboratory) to determine what types of bacteria may be present.
Lohmann and Montgomery say their results will provide invaluable baseline information for equine populations around the Saskatoon area. The study will also help them to identify the next steps for future investigations of equine airway diseases such as RAO.
All study procedures can be carried out at the owners premises, and are free of charge.
The study runs from May to August 2013. More details can be found at:
http://www.usask.ca/wcvm/vmc_clients/respiratory_study/
Wednesday, May 29, 2013
Measuring response to flexion tests
Horses were fitted with sensors on the head, pelvis and right forelimb. The sensors measured vertical pelvic movement asymmetry for both right and left hind limb strides and the average difference in maximum and minimum pelvic height between right and left hind limb strides.
The response to a hind limb flexion test was assessed by an experienced observer and compared with measurements taken with the horse trotting before and after flexion.
John Marshall, lecturer in equine surgery at the University of Glasgow, who led the study, concluded: “A positive response to flexion resulted in significant changes to objective measurements of pelvic symmetry, supporting the use of inertial sensor systems to objectively assess response to flexion tests.
Read more at equinescienceupdate.com
Saturday, March 09, 2013
Tapeworms in working donkeys in Ethiopia
The work, carried out by Dr Mulugeta Getachew formed part of his PhD studies and was funded by the Donkey Sanctuary.
Read more at www.equinescienceupdate.com
Wednesday, March 06, 2013
Effect of composting on Parascaris equorum eggs
- Constant exposure. These were placed within the centre of the windrow. Each day after the windrow had been turned, the chamber was placed back in the centre of the windrow.
- Intermittent exposure. The chambers were placed in the centre of the windrow. On alternate days, after the windrow had been turned, the chamber was placed back in the centre, or placed on the outside of the windrow.
- Control chambers were kept at 4°C.
Monday, March 04, 2013
Information sought on saddle slip
Saturday, March 02, 2013
Maggot wound therapy
Read more: www.equinescienceupdate.com
Developmental joint disease in Norwegian Standardbreds
Friday, March 01, 2013
Good and bad news for donkey lice
Thursday, February 28, 2013
Inheritance of size
Work in humans has shown that height is controlled by a vast number of genes, each with only modest effect. What about horses?
Researchers at at Cornell University, New York, have been investigating the genetic control of equine size.
Shokouh Makvandi-Nejad and colleagues in the Department of Clinical Sciences, found that in horses, like other domestic mammals, a small number of genes was responsible for controlling size.
They conducted genome-wide association scans (GWAS) on DNA from 48 individuals from 16 breeds of both extremes of size, ranging from the American Miniature and Falabella to Shire, Percheron and Suffolk Punch, as well as 48 Thoroughbreds.
They found that genetic variation at just four points (“loci”) on the chromosomes could explain most of the variation in size between breeds.
The loci, on chromosomes 3,6,9,and 11, together accounted for 83% of the variation in size differences of the breeds in the study.
“Unlike humans, which are naturally reproducing and possess many genetic variants with weak effects on size,” the researchers comment “we show that horses, like other domestic mammals carry just a small number of size loci with alleles of large effect.“
“Furthermore, three of our horse size loci contain the LCORL, HMGA2 and ZFAT genes that have previously been found to control human height.”
They add that “the simplicity of the genetic control of horse size contrasts greatly with the complexity of human size genetics but is similar to results for the domestic dog.”
See: www.equinescienceupdate.com/articles/ioh.html
Friday, January 04, 2013
Box elder seeds implicated in Seasonal Pasture Myopathy
A toxin present in the seeds of the box elder tree has been found to cause Seasonal Pasture Myopathy.
Seasonal Pasture Myopathy (SPM), a highly fatal muscle disease, occurs particularly in the Midwestern United States and eastern Canada.
Horses with SPM suffer from severe, generalised muscle weakness. They are often unable to get to their feet, or only do so with difficulty. If they are still able to walk, they have a stiff gait - especially of the hindquarters. Affected animals have elevated heart rates, and show profuse sweating and muscle twitching.
The underlying disease process has been shown to be an acquired enzyme deficiency (MADD: multiple acyl-CoA dehydrogenases deficiency) in skeletal muscle.
A similar condition, Atypical Myopathy (AM), occurs in Europe.
Recent research, led by Dr Stephanie Valberg, of the University of Minnesota, showed that the seeds of the box elder tree (Acer negundo) contain hypoglycin A, which can cause SPM.
The study involved 12 horses with seasonal pasture myopathy The researchers examined farms on which SPM had occurred, looking for common factors, and compared them with unaffected farms. Seeds from box elder trees were present on all of 11 SPM-affected pastures and 61% of 23 control pastures.
Examination of box elder seeds from the SPM pastures showed they contained hypoglycin A, a branched-chain amino acid. Once ingested, hypoglycin A is metabolised into MCPA (methylenecyclopropylacetic acid) a toxic compound, which is known to cause multiple acyl-CoA dehydrogenase deficiency (MADD).
The researchers explain that the MCPA “would have a major impact on energy generation, particularly when horses are mobilising fat because of a negative energy balance.” They add ”a negative energy balance was probably promoted in SPM horses by offering little supplemental feed while horses were housed on overgrazed pastures, in some cases during inclement weather conditions.”
Writing in the Equine Veterinary Journal, they conclude: “For the first time, SPM has been linked to a toxin in seeds abundant on autumn pastures whose identified metabolite, MCPA, is known to cause acquired MADD, the pathological mechanism behind SPM and AM.”
“Further research is required to determine the lethal dose of hypoglycin A in horses, as well as factors that affect annual seed burden and hypoglycin A content in Acer species in North America and Europe.”
Read more at www.equinescienceupdate.com
Insect compound may help laminitis
Veterinarians at the University of California, Davis, School of Veterinary Medicine have announced plans for a clinical trial of an experimental drug that has shown promise in treating horses with laminitis.
They report that four horses suffering from laminitis have been treated with the investigational anti-inflammatory drug so far. One experienced a complete remission that has lasted for more than a year, and three others have shown some improvement.
A paper on the first case has been accepted for publication by the Journal of Veterinary Anaesthesia and Analgesia. The journal editors authorised the authors to disclose their findings ahead of publication.
“This is an unusual step for us to announce this so far in advance, but because euthanasia is often the only way to alleviate pain in severe laminitis, we felt that it was important to let the veterinarians and horse owners know that this compound has shown potential as a treatment,” said Alonso Guedes, an assistant professor in the School of Veterinary Medicine.
A clinical trial to assess the drug’s safety and establish a tolerable dose for the compound is expected to begin early 2013. Further clinical trials would be needed to establish the drug’s effectiveness as a laminitis treatment.
The experimental compound, known as t-TUCB, belongs to a group of anti-inflammatory compounds called sEH (soluble epoxide hydrolases) inhibitors. It stems from a discovery made more than 40 years ago by UC Davis entomology professor Bruce Hammock while doing basic insect biology research.
In the paper, Guedes reports the case of a 4-year old Thoroughbred mare that was participating in a study into treating tendon injuries using stem cells, having been retired from racing following such an injury.
The mare developed acute laminitis, which deteriorated despite treatment including cold immersion, antibiotics, leg wraps, and nonsteroidal anti-inflammatory drugs. Before resorting to euthanasia, Guedes and the veterinary team decided to try one last treatment, t-TUCB.
The veterinarians administered the experimental compound intravenously early on the eighth day of the mare's laminitis. They report that, after receiving the first dose, the horse remained standing in the stall most of the day, became interested in her surroundings and walked voluntarily. The mare’s demeanor, posture and mobility continued to improve over four days of treatment.
No adverse affects from t-TUCB were observed, and the mare has remained laminitis-free for twelve months.
Hammock said that work aimed at moving t-TUCB and related compounds toward clinical use is advancing in several areas. He and Guedes are working on compounds with potential for targeting pain and arthritis in companion animals.
See the UC Davis video..
Thursday, January 03, 2013
Do local anaesthetics affect MRI findings?
Don't rush to carry out MRI evaluations after performing intrasynovial anaesthesia of the digital flexor tendon sheath, warn researchers at the University of Guelph, in Canada. Their work shows that local anaesthetic injected into the digital sheath results in changes that are visible on the magnetic resonance image for at least 72 hours.
The very act of injecting local anaesthetic into tissues can produce physical changes that need to be taken in to account when interpreting bone scans and ultrasound images. Until recently, knowledge of how local anaesthetic techniques influenced the appearance of magnetic resonance images was limited.
Researchers, led by Dr Belinda Black, at the University of Guelph 's Ontario Veterinary College conducted a study into whether anaesthesia of structures in the equine foot caused changes that were detectable on subsequent MRI evaluation.
The study involved fifteen healthy adult horses. None of them was lame, neither had they received non-steroidal anti-inflammatory drugs or undergone perineural or intrasynovial anaesthesia in the previous two weeks.
A baseline MRI examination of both front feet of each horse was carried out before performing the local anaesthetic techniques on one forelimb, selected at random. Mepivicaine was injected around the lateral and medial palmar digital nerves; into the podotrochlear (navicular) bursa; the digital flexor tendon sheath and the distal interphalangeal joint.
The MRI examination was repeated 24 and 72 hours after injection and the images compared.
The research team found that in the case of palmar digital nerve blocks, and injections in the podotrochlear bursa and distal interphalangeal joint, the MRI findings were not significantly different from baseline 24 and 72 hours after injection.. So, they suggest that, when these structures appear distended in MR images after diagnostic anaesthesia, it probably is a true reflection of disease and not simply due to the anaesthetic injection.
This information is particularly important, they point out, since distal interphalangeal joint effusion had been reported as the most common finding on MR images of the equine foot.
In contrast, injection of mepivicaine into the digital flexor synovial sheath resulted in distension of the sheath which was still present 24 and 72 hours later.
Dr Black comments that, although a definite time frame for resolution of digital flexor tendon sheath distension was not determined, she recommends waiting more than 3 days between intrasynovial anaesthesia of the digital flexor sheath and MRI assessment.
She concludes: “our study showed that perineural anaesthesia of the palmar digital nerves and intrasynovial anaesthesia of the podotrochlear bursa or distal interphalangeal joint in sound horses did not have any significant effect on the interpretation of subsequent MR images. However, intrasynovial anaesthesia of the digital flexor tendon sheath caused a significant iatrogenic increase in synovial fluid, which was detectable on subsequent MR images for at least 72 hours.”
Read more at www.equinescienceupdate.com
Tuesday, January 01, 2013
Hendra vaccine released
Australian horse owners will welcome the news of the introduction of a vaccine* to help protect horses against the deadly Hendra virus. The vaccine, which is available only under permit from accredited veterinarians, will also assist in breaking the cycle of transmission that puts humans at risk of contracting this potentially lethal virus.
Hendra virus is a serious zoonotic infectious disease transmitted by flying foxes shedding the virus in their saliva, urine, aborted foetuses and/or reproductive fluids. Horses are thought to contract the virus by ingesting feed or water contaminated with one of these sources of infection.
With a high mortality rate, Hendra virus has claimed the lives of 81 horses, including nine deaths in 2012 alone. There is no known cure, so the vaccine is positioned to become the most effective defence against this virus.
“This vaccine significantly decreases the risk of exposure to Hendra virus for horse owners, handlers and veterinarians. For that reason, the Australian Veterinary Association recommends that all horses be vaccinated against the Hendra virus,” said Dr Ben Gardiner, President, Australian Veterinary Association (AVA).
“The vaccine will also help to protect the health of horses and is a major win for anyone working in the equine industry, including veterinarians.”
Read more at www.equinescienceupdate.com
Equine Grass Sickness Vaccine Study
Researchers at the Animal Health Trust, Newmarket and the Royal (Dick) School of Veterinary Studies, University of Edinburgh are collaborating in a pilot trial of a vaccine to protect against equine grass sickness.
Equine grass sickness (EGS) is a frequently fatal disease of horses; more than 85% of affected animals die. It has been reported in several northern European countries, but occurs most frequently in Great Britain, having been first recognised in Scotland over 100 years ago.The cause is still not known for certain, but it seems likely that toxins from Clostridium botulinum type C are involved.
The pilot study, based in eastern Scotland, has enrolled a total of 100 horses and ponies. This small scale trial is in preparation for a full vaccine trial, which will involve at least 1000 horses and ponies, and is likely to commence in 2013-2014 subject to securing sufficient funding.
Although there is still a lot of work to do before launching the full nationwide vaccine trial, this initial pilot study will help to ensure that the trial design will be practical to perform on a larger scale.
Dr Jo Ireland of the Animal Health Trust, who is piloting the vaccine trial, explains: ‘This is very exciting news and we are working flat out to get the study up and running. There is still a lot of work to do before launching the full nationwide vaccine trial, and this initial study will help us to ensure that the trial design will be practical to perform on a larger scale.’
The Equine Grass Sickness Fund is spearheading the campaign to raise funds for the full vaccine trial, which is being run in collaboration with the Animal Health Trust, The (Dick) Vet and Liverpool University’s School of Veterinary Studies.
Kate Thomson, spokesperson for the Fund, said ‘We are over the moon that the vaccine trial is finally here, but fundraising now starts in earnest to ensure that the full trial can go ahead. Grass sickness takes a terrible annual death toll, and we are appealing to every horse owner in the UK to help bring an end to the disease by donating to this cause’.
If you would like to support the equine grass sickness vaccine trial by making a donation to the Equine Grass Sickness Fund, please visit www.grasssickness.org.uk
New study to investigate headshaking in horses
Headshaking syndrome is an intermittent, apparently involuntary, movement of the horse’s head. It may occur at rest or at exercise. The signs may be so severe as to prevent the horse being ridden.
It is not an uncommon problem, and proves very frustrating to treat. It is thought to be due to pain in the sensory nerves supplying the face (trigeminal nerve).
Although some progress has been made towards both diagnosing and treating the condition in horses, the pathology of the disease remains unknown and further research is needed.
Caudal compression of the infraorbital nerve currently offers the best prognosis for a successful outcome compared with other treatments.
The procedure was developed by Veronica Roberts and colleagues at the University of Liverpool's Veterinary School. Now Clinical Fellow in Equine Medicine in the University of Bristol’s School of Veterinary Sciences, Roberts has received a grant from the British Neuropathological Society to investigate possible focal demyelination of the nerve as a cause of headshaking in horses.
Demyelination is the most common cause of trigeminal neuralgia in people, so the research team will look to see if it is involved in the equine condition. They will collaborate with Seth Love, Professor of Neuropathology at the University of Bristol's School of Clinical Sciences, as he has carried out work in this area in people.
To find a more effective treatment and to understand the disease, Dr Roberts is requesting that anyone who is considering euthanizing a horse due to headshaking to contact her for possible inclusion in her study.
Monday, October 29, 2012
Mobile light therapy
A new way to advance the breeding season in mares is being developed following research into the use of light-emitting diodes (LEDs) to inhibit melatonin secretion.
Thoroughbred breeders aim to have foals born as soon as possible after the official birthday of January 1st (in the northern hemisphere.) This gives them a head start in size and maturity when competing against other horses in the same age group, both at sales and subsequently at the race track.
However, breeding early in the year is at odds with the horse's natural breeding season, which occurs some months later.
Artificial light is commonly used to advance the breeding season in mares. When an early foal is desired, breeders will put the mare "under lights" - keeping the barn lights on in the winter, to mimic the lengthening days that initiate the natural breeding season.
The hormone responsible for controlling this seasonal variation in response to change in day length is melatonin. It is secreted by the pineal gland in response to darkness.
Researchers at the University College Dublin's School of Agriculture and Food Science, have been examining the effect of different levels of blue light on melatonin production.
Four healthy 5-year-old TB mares took part in the study, which was conducted around the vernal (spring) equinox, so the mares were accustomed to equal 12 hour periods of light and darkness. For the duration of the study the mares were housed in a light-tight barn with artificial lighting timed to mimic the conditions outside .
The researchers used LEDs (emitting blue light of wavelength 468nm) set in a head mask to investigate the effect of blue light on melatonin secretion in the horse. (Blue light (465–485 nm) has been found to be the most efficient for inhibiting melatonin secretion in humans.)
Blood samples were collected through indwelling catheters at the end of hour-long periods of exposure to dark or to varying intensities of light. The light was directed at either both eyes or just one eye.
All samples, except the first, collected after exposure to “daylight”, occurred during the dark phase of the 24 h cycle.
The results showed that blue light inhibited the production of melatonin. The inhibitory effect occurred regardless of whether the light was administered to one or both eyes.
Melatonin levels were significantly lower after exposure to 10 lux, 50 lux, 100 lux as well as barn light, than they were after an hour of darkness. Melatonin levels after exposure to 3 lux were not significantly different from those recorded in darkness.
Lead researcher Dr Barbara Murphy, concludes that “melatonin inhibition can be achieved by exposing a single eye to low wavelength blue light.” She adds that “this is a novel finding with important implications for management of artificial lighting regimens in horses.”
“The light mask represents a safe cost-effective method of administering timed low-level light to a single eye so that mares can be maintained outdoors in their natural environment, avoiding the costs of indoor maintenance, while effectively advancing the onset of the breeding season to meet industry timelines.”
Read more at equinescienceupdate.com
